Showing results 21 to 29 of 29
< previous
| Preview | Issue Date | Title / Name | Author(s) | Type |
| 2020 | Real-world impact of anti-HER2 therapy-related cardiotoxicity in patients with advanced HER2-positive breast cancer | Conduit, C.; de Boer, R. H.; Lok, S.; Gibbs, Peter; Malik, Laeeq, et al | Journal Article | |
| Jan-2025 | Real-world impact of pembrolizumab availability for deficient mismatch repair metastatic colorectal cancer | Loft, Matthew; Wong, Vanessa; Kosminder, Suzanne; Wong, Rachel; Shapiro, Jeremy, et al | Journal Article | |
| 18-Nov-2024 | Real-world impact of pembrolizumab availability for deficient mismatch repair metastatic colorectal cancer | Loft, Matthew; Wong, Vanessa; Kosmider, Suzanne; Wong, Rachel; Shapiro, Jeremy, et al | Journal Article | |
| 2021 | Real-world outcomes in patients with brain metastases secondary to HER2-positive breast cancer: An Australian multi-centre registry-based study | Tung, Iris; Moldovan, Cristina; Wong, Vanessa; De Boer, Richard; Gibbs, Peter, et al | Conference Paper | |
| Oct-2022 | Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based Study | Tung, Iris; Moldovan, Cristina; Wong, Vanessa; De Boer, Richard; Yeo, Belinda, et al | Journal Article | |
| 2020 | Real-world uptake of bone modifying agents in advanced breast cancer with bone metastases-Prospective data from a multi-site Australian registry | Wong, Vanessa; De Boer, Richard; Anton, Angelyn; Malik, Laeeq; Greenberg, Sally, et al | Conference Paper | |
| 2022 | Regional Victorian trials alliance: Linkages, Innovation, Special populations, Equity (ReViTALISE) project: Addressing disparity in regional populations | Long, Donna; Collins, Ian M.; Harris, Samuel; Torres, Javier; Faisal, Wasek, et al | Conference Paper | |
| 2017 | Tumour Characteristics and Treatment Patterns in Relapsed Metastatic HER2 Positive Breast Cancer | Yip, Desmond; Lok, Sheau Wen; Gibbs, Peter; Lombard, Janine; Richardson, Gary, et al | Conference Paper | |
| 2021 | Uptake of bone-modifying agents in patients with HER2+ metastatic breast cancer with bone metastases - prospective data from a multi-site Australian registry | Wong, Vanessa; de Boer, Richard; Dunn, Catherine; Anton, Angelyn; Malik, Laeeq, et al | Journal Article | |
